Pediatr. praxi. 2010;11(2):135-136

Significance of HPV vaccination in preventing cervical adenocarcinoma

MUDr.Petr Halada
Porodnická a gynekologická klinika LF UK a FN Hradec Králové

In recent years, there has been an increase in the incidence of adenocarcinoma of the uterine cervix and a decrease in the incidence of

the squamous-cell form. Regarding vaccination against HPV, cross-protection is encountered. Antibodies formed during the response

generated by vaccine antigens can also provide protection against other closely related antigens. Thus, the spectrum of vaccine efficacy

is extended. This fact may play an essential role in preventing not only squamous-cell carcinomas of the uterine cervix but also

adenocarcinomas.

Keywords: cervical adenocarcinoma, HPV, vaccination

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Halada P. Significance of HPV vaccination in preventing cervical adenocarcinoma. Pediatr. praxi. 2010;11(2):135-136.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Cibula D. Onkogynekologie, 1. vyd. Praha: Grada Publishing 2009: 394.
    2. Burd EM, et al. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003; 16: 1-17. Go to original source... Go to PubMed...
    3. Kjaer SK, et al. Adenocarcinomas of the uterine cervix - the epidemiology of an increasing problem. Epidemiol. Rev. 1993; 15: 486-498. Go to original source... Go to PubMed...
    4. Munoz N, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527. Go to original source... Go to PubMed...
    5. Bosch FX, et al. Human papillomavirus and cervical cancer - burden and assessment of causality. J Natl Cancer Inst Monogr 2003; 31: 3-13. Go to original source... Go to PubMed...
    6. Vinh-Hung V, et al. Prognostic value of histopatology and trends in cervical cancer: a SEER population study. BMC Cancer 2007; 7: 164-176. Go to original source... Go to PubMed...
    7. Hayes MM, et al. Cytological aspects of uterine cervical adenocarcinoma, adenosquamous carcinoma and combined adenocarcinoma-squamous carcinoma: appraisal of diagnostic criteria for in situ versus invasive lesions. Cytopathology 1997; 8: 397-408. Go to original source... Go to PubMed...
    8. Harriet OS, et al. Adenocarcinoma in situ of the cervix: Sensitivity of detection by cervical smear. Cancer 2002; 6: 319-322. Go to original source...
    9. Parkin DM, et al. The burden of HPV - related cancers. Vaccine 2006; 24(Suppl. 3): 11-25. Go to original source... Go to PubMed...
    10. Hildesheim A, et al. Risk factors for rapid-onset cervical cancer. Am J Obstet Gynecol 1999; 180: 571-577. Go to original source... Go to PubMed...
    11. Bosch FX, et al. Epidemiology and natural history of human papillomavirus infection and type-specific implications in cervical neoplasia. Vaccine, 2008; 26S: K1-K16. Go to original source... Go to PubMed...
    12. Souhrn údajů o přípravku Silgard (Merk Sharp Dohme Ltd.), revize textu 20. 9. 2009.
    13. Souhrn údajů o přípravku Cervarix (GlaxoSmithKline Biologicals s. a.), revize textu 24. 7. 2009.

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.